Medicines Patent Pool (MPP) 藥品專利聯盟

Medicines Patent Pool (MPP)
繁：藥品專利聯盟
简：药品专利联盟

聯合國支持的「藥品專利聯盟」(Medicines Patent Pool, MPP)今天(20日)表示，已經和近30家學名藥製造商簽署協議，將生產低成本版本的美國默沙東集團(Merck & Co)治療COVID-19(2019年冠狀病毒疾病)的口服藥「莫納皮拉韋」(Molnupiravir)。

27家藥廠簽協議 將生產默沙東的COVID口服藥（2022年1月 20日）。中央廣播電臺，取自https://www.rti.org.tw/news/view/id/2122636

Thirty five generic drugmakers around the world will make cheap versions of Pfizer Inc’s (PFE.N) highly effective COVID-19 oral antiviral Paxlovid to supply the treatment in 95 poorer countries, the U.N.-backed Medicines Patent Pool (MPP) said on Thursday.

Generic drugmakers sign on to make cheap version of Pfizer COVID pill. (2022, Mar 17). Reuters. Retrieved from https://www.reuters.com/business/healthcare-pharmaceuticals/generic-drugmakers-sign-make-cheap-version-pfizer-covid-pill-2022-03-17/